JP2012524772A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524772A5
JP2012524772A5 JP2012506584A JP2012506584A JP2012524772A5 JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5 JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5
Authority
JP
Japan
Prior art keywords
composition
triglycerides
omega
pharmaceutical composition
buccal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506584A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524772A (ja
JP5795760B2 (ja
Filing date
Publication date
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Application filed filed Critical
Priority claimed from PCT/GB2010/050672 external-priority patent/WO2010122356A1/en
Publication of JP2012524772A publication Critical patent/JP2012524772A/ja
Publication of JP2012524772A5 publication Critical patent/JP2012524772A5/ja
Application granted granted Critical
Publication of JP5795760B2 publication Critical patent/JP5795760B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506584A 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤 Expired - Fee Related JP5795760B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0906971.7 2009-04-23
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
GBPCT/GB2009/050415 2009-04-23
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (3)

Publication Number Publication Date
JP2012524772A JP2012524772A (ja) 2012-10-18
JP2012524772A5 true JP2012524772A5 (enExample) 2013-05-02
JP5795760B2 JP5795760B2 (ja) 2015-10-14

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506584A Expired - Fee Related JP5795760B2 (ja) 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤

Country Status (23)

Country Link
US (4) US20120157518A1 (enExample)
EP (1) EP2424523B1 (enExample)
JP (1) JP5795760B2 (enExample)
CN (1) CN102395362B (enExample)
AU (1) AU2010240654C1 (enExample)
BR (1) BRPI1014887A8 (enExample)
CA (1) CA2756925A1 (enExample)
DK (1) DK2424523T3 (enExample)
ES (1) ES2390046T3 (enExample)
HR (1) HRP20120711T1 (enExample)
IL (1) IL215453A (enExample)
ME (1) ME02008B (enExample)
MX (1) MX2011010961A (enExample)
MY (1) MY155646A (enExample)
NZ (1) NZ595469A (enExample)
PL (1) PL2424523T3 (enExample)
PT (1) PT2424523E (enExample)
RS (1) RS52430B (enExample)
RU (1) RU2501550C2 (enExample)
SG (1) SG175162A1 (enExample)
SI (1) SI2424523T1 (enExample)
WO (1) WO2010122356A1 (enExample)
ZA (1) ZA201107088B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
CA2756879A1 (en) * 2009-04-23 2010-10-28 Londonpharma Ltd. Sublingual pharmaceutical composition comprising a neutral oil
CA2898113C (en) * 2013-01-14 2022-05-31 Health Clinics Limited Combination cancer therapeutics and uses thereof
US20170326102A1 (en) 2014-11-27 2017-11-16 Cipla Limited Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
NZ509324A (en) * 1998-07-14 2003-07-25 Bayer Ag Antiparasitic artemisinin derivatives (endoperoxides)
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
US20060257463A1 (en) * 2002-05-31 2006-11-16 University Of Mississippi Transmucosal delivery of cannabinoids
JP2005529938A (ja) * 2002-06-06 2005-10-06 ユニバーシティ オブ ワシントン 癌の発症を予防または遅延するためのアルテミシニン様化合物を使用する方法
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Similar Documents

Publication Publication Date Title
JP2022180461A5 (enExample)
JP2011500781A5 (enExample)
JP5822991B2 (ja) 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法
JP2013511496A5 (enExample)
JP2015528491A5 (enExample)
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
JP2016517434A5 (enExample)
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
JP2013542247A5 (enExample)
NZ605888A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
JP2014515373A5 (enExample)
AR065580A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2015507020A5 (enExample)
RU2011139637A (ru) Сублингвальная спреевая композиция, содержащая дигидроартемизинин
RU2014137190A (ru) Комбинации ингибитора гистон-деацетилазы и пазопаниба и их применение
RU2010138650A (ru) Комбинация, включающая паклитаксел, для лечения рака яичников
JP2016505050A5 (enExample)
RU2012108144A (ru) Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами
US20220305223A1 (en) Olfactory Delivery Device, System and Method for the Delivery of a Variety of Pharmaceutical Agents
PE20130782A1 (es) Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
JP2015524460A5 (enExample)
CN104869986A (zh) 用于癌症的组合疗法
ATE546133T1 (de) Orale dosierform mit trisubstituierten glycerin- verbindungen
JP2017514829A5 (enExample)